PFS Clinical Revenue and Competitors

Madison, WI USA

Location

N/A

Total Funding

Research

Industry

Estimated Revenue & Valuation

  • PFS Clinical's estimated annual revenue is currently $2.4M per year.(i)
  • PFS Clinical's estimated revenue per employee is $81,600

Employee Data

  • PFS Clinical has 30 Employees.(i)
  • PFS Clinical grew their employee count by -32% last year.

PFS Clinical's People

NameTitleEmail/Phone
1
Manager, Quality and DevelopmentReveal Email/Phone
2
Senior Clinical Research AnalystReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1090M58388%$38.4M$6.3B
Add Company

What Is PFS Clinical?

PFS Clinical provides customizable solutions to the unique challenges inherent to clinical research. We've built a team of experts in critical areas of research operations based on a thorough understanding of the needs and challenges of this industry. We serve all types of research institutions with a flexible model that allows us to efficiently match your needs with our expertise. Our core services include (but are not limited to) coverage analysis, budget development/negotiations, contract development/negotiations, training, and CTMS support.

keywords:N/A

N/A

Total Funding

30

Number of Employees

$2.4M

Revenue (est)

-32%

Employee Growth %

N/A

Valuation

N/A

Accelerator

PFS Clinical News

2022-04-20 - Maintenance Rucaparib After Chemo Extends PFS in Some ...

The PFS rate was 60% in the rucaparib arm and 100% in the placebo arm. ... in Palo Alto, Calif., told Clinical Oncology News.

2022-04-20 - BeiGene Presents Updated Results from Phase 3 ...

An updated analysis of the primary endpoint (PFS) and two secondary ... placebo-controlled Phase 3 clinical trial (NCT03924986) designed to...

2022-04-13 - Pfizer's Lorbrena shows PFS improvement in Phase III lung ...

Pfizer's Lorbrena shows PFS improvement in Phase III lung cancer trial ... advanced lung cancer patients in Phase III CROWN clinical trial.

2019-09-08 - Clinical Catch-Up: September 2-8

Last week was a busy week for clinical trial results. .... least 18 patients with the primary endpoint progression-free survival (PFS) at six months.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A3011%N/A
#2
$5M30-6%N/A
#3
$6.5M3011%N/A
#4
$5.4M30-9%N/A
#5
$6.5M30-3%N/A